Published :
Tables : 51
Figures : 48
Category : Healthcare
No. of Pages : 224
Report Code : HC-U3139
Organ Preservation Market is poised to value over USD 300 million by 2028 end at a CAGR of over 6.3% during the forecast period 2022 to 2028. Organ preservation is the ability to preserve ex vivo organ viability as well as to restore normal organ function when blood flow is restored. It is the supply line for organ transplantation. For patients with end-stage disease, organ transplantation is the most effective treatment. In the process of transplanting an organ, the required organ is removed from the donor's body, then stored and transported. Depending on the requirements, the organ is normally washed with a preservation solution and stored according to its specific preservation needs. Providing preservation solutions and techniques is vital to donor organ quality, which directly impacts morbidity and survival after transplantation. The most frequent cold storage solution in organ preservation is the UW solution. Originally developed for pancreatic transplantation, it has been widely used to preserve various organs, including the kidney, liver, and bowel. This intracellular preservation solution has low sodium and high potassium concentrations to mimic intracellular conditions.Celsior is a type of extracellular preservation solution used to preserve cardiac grafts in cold storage. Currently, the method is used to preserve the heart, lungs, liver, pancreas, kidneys, and small bowels. Celsior is a low-potassium, high-sodium solution. In addition to the above solutions, there are numerous other solutions used for cold storage preservation of organs. The composition of each solution may vary, but the key strategy is similar: minimize ischemic/hypoxic injury and maximize organ function after reperfusion using colloids, impermeants, electrolytes, antioxidants, and nutrients. Clinically, delayed graft function (DGF) or primary nonfunction (PNF) occur when an organ doesn't recover quickly from implantation surgery and reperfusion. By definition, delayed graft function is impaired function that returns to normal over time. Alternatively, graft PNF indicates that the organ will not be able to function or survive. A growing number of chronic diseases and organ failures among the world's population has increased the need for organ preservation. Growing geriatric population has pushed up market demand. Smoking, drinking, and other lifestyle choices have led to the development of organ failure, as well as an increase in the need to preserve organs at the end of life. A report published by FutureWise Market Research provides an in-depth analysis of Organ Preservation Market trends that will impact the market's growth. Additionally, it contains detailed information on the profitability graph, SWOT analysis, market share, and regional expansion of this business. In addition, this report offers information on the current position of prominent market players in the competitive landscape analysis of this market. By the end of the forecast period, the Organ Preservation Market is predicted to achieve substantial growth, according to a research study conducted by FutureWise research analysts. In the report, it is explained that this industry is predicted to exhibit a noteworthy growth rate. The report includes highly detailed information about the current market valuation as well as the segmentation of this industry as well as the growth opportunities within this business niche. Major players included in the Organ Preservation Market: Bristol-myers Squibb Xvivo Perfusion AB Paragonix Technologies Franz Kohler Chemie Gmbh Biolife Solutions Inc. Claris Lifesciences Limited Lifeline Scientific Tolerotech Inc. 21st Century Medicine Cryolife Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Organ Preservation Market Segmentation: By Solution University of Wisconsin (UW) Custodial HTK Perfadex Others (Celsior & Euro-Collins) By Technique Static Cold Storage Hypothermic Machine Perfusion Normothermic Machine Perfusion By Organ Type Kidneys Liver Lung Heart Others (Intestine & Pancreas) By Region North America Europe Asia-Pacific Latin America Middle East and Africa Organ Preservation Market Sample Video: Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Organ Preservation Market By Solution, By Technique, By Organ Type and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Organ preservation is the ability to preserve ex vivo organ viability as well as to restore normal organ function when blood flow is restored. It is the supply line for organ transplantation. For patients with end-stage disease, organ transplantation is the most effective treatment. In the process of transplanting an organ, the required organ is removed from the donor's body, then stored and transported. Depending on the requirements, the organ is normally washed with a preservation solution and stored according to its specific preservation needs. Providing preservation solutions and techniques is vital to donor organ quality, which directly impacts morbidity and survival after transplantation.
The most frequent cold storage solution in organ preservation is the UW solution. Originally developed for pancreatic transplantation, it has been widely used to preserve various organs, including the kidney, liver, and bowel. This intracellular preservation solution has low sodium and high potassium concentrations to mimic intracellular conditions.Celsior is a type of extracellular preservation solution used to preserve cardiac grafts in cold storage. Currently, the method is used to preserve the heart, lungs, liver, pancreas, kidneys, and small bowels. Celsior is a low-potassium, high-sodium solution. In addition to the above solutions, there are numerous other solutions used for cold storage preservation of organs. The composition of each solution may vary, but the key strategy is similar: minimize ischemic/hypoxic injury and maximize organ function after reperfusion using colloids, impermeants, electrolytes, antioxidants, and nutrients.
Clinically, delayed graft function (DGF) or primary nonfunction (PNF) occur when an organ doesn't recover quickly from implantation surgery and reperfusion. By definition, delayed graft function is impaired function that returns to normal over time. Alternatively, graft PNF indicates that the organ will not be able to function or survive. A growing number of chronic diseases and organ failures among the world's population has increased the need for organ preservation. Growing geriatric population has pushed up market demand. Smoking, drinking, and other lifestyle choices have led to the development of organ failure, as well as an increase in the need to preserve organs at the end of life.
A report published by FutureWise Market Research provides an in-depth analysis of Organ Preservation Market trends that will impact the market's growth. Additionally, it contains detailed information on the profitability graph, SWOT analysis, market share, and regional expansion of this business. In addition, this report offers information on the current position of prominent market players in the competitive landscape analysis of this market.
By the end of the forecast period, the Organ Preservation Market is predicted to achieve substantial growth, according to a research study conducted by FutureWise research analysts. In the report, it is explained that this industry is predicted to exhibit a noteworthy growth rate. The report includes highly detailed information about the current market valuation as well as the segmentation of this industry as well as the growth opportunities within this business niche.
Major players included in the Organ Preservation Market:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Organ Preservation Market Segmentation:
By Solution
By Technique
By Organ Type
By Region
Organ Preservation Market Sample Video:
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Organ Preservation Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Organ Preservation Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Organ Preservation Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Organ Preservation Market, By Solution Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. University of Wisconsin (UW) 7.2. Custodial HTK 7.3. Perfadex 7.4. Others (Celsior & Euro-Collins) 8. Organ Preservation Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Static Cold Storage 8.2. Hypothermic Machine Perfusion 8.3. Normothermic Machine Perfusion 9. Organ Preservation Market, By Organ Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Kidneys 9.2. Liver 9.3. Lung 9.4. Heart 9.5. Others (Intestine & Pancreas) 10. North America Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Bristol-myers Squibb 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Xvivo Perfusion AB 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Paragonix Technologies 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Franz Kohler Chemie Gmbh. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Biolife Solutions Inc. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Claris Lifesciences Limited 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Lifeline Scientific 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Tolerotech Inc. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. 21st Century Medicine 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Cryolife Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Organ Preservation Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Organ Preservation Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Organ Preservation Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Organ Preservation Market, By Solution Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. University of Wisconsin (UW) 7.2. Custodial HTK 7.3. Perfadex 7.4. Others (Celsior & Euro-Collins)
8. Organ Preservation Market, By Technique Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Static Cold Storage 8.2. Hypothermic Machine Perfusion 8.3. Normothermic Machine Perfusion
9. Organ Preservation Market, By Organ Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Kidneys 9.2. Liver 9.3. Lung 9.4. Heart 9.5. Others (Intestine & Pancreas)
10. North America Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Organ Preservation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Bristol-myers Squibb 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Xvivo Perfusion AB 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Paragonix Technologies 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Franz Kohler Chemie Gmbh. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Biolife Solutions Inc. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Claris Lifesciences Limited 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Lifeline Scientific 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Tolerotech Inc. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. 21st Century Medicine 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Cryolife Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics